comparemela.com
  1. Home
  2. Live Updates
  3. Shorla Oncology - Breaking News

Latest Breaking News On - Shorla oncology - Page 7 : comparemela.com

All the winners at the 2023 Goss ie Women of the Year Awards

All the winners at the 2023 Goss ie Women of the Year Awards
goss.ie - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from goss.ie Daily Mail and Mail on Sunday newspapers.

United kingdomUniversity collegeNew south walesUnited statesDun laoghaireCounty dun laoghaire rathdownCounty south dublinSouth tipperaryRepublic of irelandBill clintonOrlaith ryan shorlaMolly mae hagueNiamh donnellyAlexandra ryanMuireann oconnellOrlaith ryan

All the winners at the 2023 Goss ie Women of the Year Awards

All the winners at the 2023 Goss ie Women of the Year Awards
goss.ie - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from goss.ie Daily Mail and Mail on Sunday newspapers.

University collegeNew south walesCounty south dublinDun laoghaireCounty dun laoghaire rathdownUnited kingdomSouth tipperaryUnited statesRepublic of irelandRhasidat adelekeBrian mcevoyRuby okellyBill clintonLiz nugentAlexandra ryanMolly mae hague

Shorla Oncology Announces Licensing Agreement and Strategic Partnership for Rights to Market Chemotherapy Drug, PIP-101, in the United States

CAMBRIDGE, Mass. (BUSINESS WIRE) Jul 6, 2023

United statesUnited kingdomOrlaith ryanSharon cunninghamRachel ford hutmanDrug administrationNew drug applicationShorla oncologyNelarabine injectionT cell leukemiaRachel fordBusiness wire

With no Amgen merger, Horizon Therapeutics faces crisis | Crain s Chicago Business

Crain's Health Pulse is your source for actionable, exclusive and inside news on the health care industry.

United statesHerry valleyUnited kingdomErik huddlestonSam mencoffTom soulelesKaren andersenJohn boumanAstellas pharmaTim sullivanOmar aquinoWinston strawnEzra friedmanLeslie rydbergHolly vedovaRamita tandon

Shorla Oncology & EVERSANA Announce Commercial Launch of Recent FDA-Approved Nelarabine Injection for the Treatment of T-cell Leukemia Across the United States

/PRNewswire/ Shorla Oncology ( Shorla ), a U.S.-Ireland pharmaceutical company, and EVERSANA®, a leading provider of commercialization services to the life.

United statesUnited kingdomJim langSharon cunninghamOrlaith ryanMatt braunRachel ford hutmanNelarabine injectionT cell acute lymphoblastic leukemiaT cell lymphoblastic lymphomaShorla oncologyImportant safety informationPrescribing informationBoxed warning

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.